UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-34566
China Biologic Products Holdings, Inc.
(Exact name of registrant as specified in its charter)
18th Floor, Jialong International Building
19 Chaoyang Park Road
Chaoyang District, Beijing 100125
People’s Republic of China
Tel: 86-10-6598-3111
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, par value US$0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | x |
| Rule 12g-4(a)(2) | ¨ |
| Rule 12h-3(b)(1)(i) | x |
| Rule 12h-3(b)(1)(ii) | ¨ |
| Rule 15d-6 | ¨ |
Approximate number of holders of record as of the certification or notice date: one
Pursuant to the requirements of the Securities Exchange Act of 1934, China Biologic Products Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: April 30, 2021 | CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. | |
| By: | /s/ Joseph Chow | |
| Name: | Joseph Chow | |
| Title: | Chairman of the Board of Directors | |
